Literature DB >> 18004883

Substrate chirality and specificity of diacylglycerol kinases and the multisubstrate lipid kinase.

Richard M Epand1, Yulia V Shulga, Heath C Timmons, Alexandra L Perri, Jitendra D Belani, Kirishanth Perinpanathan, Laura Beth Johnson-McIntire, Sandra Bajjalieh, Armela O Dicu, Cynthia Elias, Scott D Rychnovsky, Matthew K Topham.   

Abstract

The alpha, zeta, and epsilon isoforms of diacylglycerol kinase exhibit a high degree of stereospecificity in the phosphorylation of diacylglycerol. In comparison, a multiple lipid kinase, MuLK, shows much less stereospecificity, phosphorylating 1,2-dioleoylglycerol only approximately 2-3 times more rapidly than 2,3-dioleoylglycerol. The alpha and zeta isoforms of diacylglycerol kinase are inhibited by 2,3-dioleoylglycerol, but not the more substrate-selective epsilon isoform. The inhibition by 2,3-dioleoylglycerol is uncompetitive. This corresponds to a kinetic scheme in which the inhibitor can bind to the enzyme-substrate complex, but not to the free enzyme. Our data indicate that despite their similar structures, 1,2-dioleoylglycerol and 2,3-dioleoylglycerol do not compete for the active site of these three isoforms of diacylglycerol kinase. We suggest that the 2,3-dioleoylglycerol binds to a site on the alpha and zeta isoforms of diacylglycerol kinase that is exposed as a consequence of the substrate binding to the active site. The chiral specificity of these enzymes thus mimics the substrate specificity, with MuLK being the least selective and the epsilon isoform of diacylglycerol kinase exhibiting the greatest selectivity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18004883     DOI: 10.1021/bi701584v

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.321


  8 in total

1.  Acylglycerol kinase augments JAK2/STAT3 signaling in esophageal squamous cells.

Authors:  Xiuting Chen; Zhe Ying; Xi Lin; Huanxin Lin; Jueheng Wu; Mengfeng Li; Libing Song
Journal:  J Clin Invest       Date:  2013-05-08       Impact factor: 14.808

2.  Substrate specificity of diacylglycerol kinase-epsilon and the phosphatidylinositol cycle.

Authors:  Yulia V Shulga; Matthew K Topham; Richard M Epand
Journal:  FEBS Lett       Date:  2011-11-19       Impact factor: 3.864

3.  Endocannabinoids and diacylglycerol kinase activity.

Authors:  Arpita Gantayet; Januvi Jegatheswaran; Gowtham Jayakumaran; Matthew K Topham; Richard M Epand
Journal:  Biochim Biophys Acta       Date:  2010-12-29

4.  Integration of metabolomics, lipidomics and clinical data using a machine learning method.

Authors:  Animesh Acharjee; Zsuzsanna Ament; James A West; Elizabeth Stanley; Julian L Griffin
Journal:  BMC Bioinformatics       Date:  2016-11-22       Impact factor: 3.169

5.  Diacylglycerol kinase epsilon is selective for both acyl chains of phosphatidic acid or diacylglycerol.

Authors:  Michael Lung; Yulia V Shulga; Pavlina T Ivanova; David S Myers; Stephen B Milne; H Alex Brown; Matthew K Topham; Richard M Epand
Journal:  J Biol Chem       Date:  2009-09-10       Impact factor: 5.486

6.  Acylglycerol kinase promotes cell proliferation and tumorigenicity in breast cancer via suppression of the FOXO1 transcription factor.

Authors:  Xi Wang; Chuyong Lin; Xiaohui Zhao; Aibin Liu; Jinrong Zhu; Xinghua Li; Libing Song
Journal:  Mol Cancer       Date:  2014-05-08       Impact factor: 27.401

7.  Overexpression of acylglycerol kinase is associated with poorer prognosis and lymph node metastasis in nasopharyngeal carcinoma.

Authors:  Qian Zhu; Su-Mei Cao; Huan-Xin Lin; Qi Yang; Sai-Lan Liu; Ling Guo
Journal:  Tumour Biol       Date:  2015-10-07

Review 8.  DAG tales: the multiple faces of diacylglycerol--stereochemistry, metabolism, and signaling.

Authors:  Thomas Oliver Eichmann; Achim Lass
Journal:  Cell Mol Life Sci       Date:  2015-07-08       Impact factor: 9.261

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.